CURIS, INC. Available-for-sale Securities, Amortized Cost Basis
CURIS, INC. (CRIS) had Available-for-sale Securities, Amortized Cost Basis of $21.95 million as of 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAmortizedCost · last filed 2018-03-08
- 2017-12-31: Available-for-sale Securities, Amortized Cost Basis $21.95M.
- 2017-09-30: Available-for-sale Securities, Amortized Cost Basis $19.39M.
- 2017-06-30: Available-for-sale Securities, Amortized Cost Basis $24.37M.
- 2017-03-31: Available-for-sale Securities, Amortized Cost Basis $18.39M.
| Period end | Available-for-sale Securities, Amortized Cost Basis | Available-for-sale Securities, Amortized Cost Basis as first filed |
|---|---|---|
| 2017-12-31 | $21.95M 10-K · filed 2018-03-08 | |
| 2017-09-30 | $19.39M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $24.37M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $18.39M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $18.45M 10-K · filed 2018-03-08 | |
| 2016-09-30 | $32.66M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $52.97M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $58.37M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $49.07M 10-K · filed 2017-03-09 | $49.07M 10-K · filed 2016-02-29 |
| 2015-09-30 | $64.76M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $67.70M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $83.69M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $42.80M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $46.66M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $44.60M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $48.86M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $47.59M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $48.43M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $47.38M 10-Q · filed 2013-08-08 | |
| 2012-12-31 | $42.78M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $33.33M 10-Q · filed 2012-11-06 | |
| 2012-06-30 | $32.61M 10-Q · filed 2012-08-09 | |
| 2011-12-31 | $22.60M 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |